Literature DB >> 24709457

IUGR and infections.

Stefania Longo1, Alessandro Borghesi2, Chryssoula Tzialla2, Mauro Stronati2.   

Abstract

Intra-uterine growth retardation (IUGR) is usually defined as impaired growth and development of the fetus and/or its organs during gestation. Infants are defined small for gestational age (SGA), following IUGR, when the birth weight is below the 10th percentile. Pre-natal congenital infections caused by T. gondii, rubella, cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV), and Treponema are associated with, and account for, approximately 5 to 15% of IUGR. On the other hand, SGA preterm infants are at increased risk of post-natal infection compared to their age-matched appropriately grown controls, in particular nosocomial infection, irrespective of the responsible pathogen. One possible mechanism is the retarded development in the immune system which has been described in association with IUGR. Indeed, SGA infants have a disproportionately small thymus and low leukocyte, lymphocyte and macrophage counts. However, immune therapies, including prophylactic intravenous immunoglobulins and GM-CSF have not proven to be effective in reducing the incidence of sepsis, and further research is required.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  IUGR; Infection; Intrauterine growth retardation; Newborn infant; SGA; Sepsis

Mesh:

Year:  2014        PMID: 24709457     DOI: 10.1016/S0378-3782(14)70014-3

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  22 in total

Review 1.  Immune dysfunction in developmental programming of type 2 diabetes mellitus.

Authors:  Thea N Golden; Rebecca A Simmons
Journal:  Nat Rev Endocrinol       Date:  2021-02-01       Impact factor: 43.330

2.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

Review 3.  Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.

Authors:  Yiska Weisblum; Amos Panet; Ronit Haimov-Kochman; Dana G Wolf
Journal:  Semin Immunopathol       Date:  2014-10-08       Impact factor: 9.623

4.  Effect of maternal curcumin supplementation on intestinal damage and the gut microbiota in male mice offspring with intra-uterine growth retardation.

Authors:  Lina Qi; Jingle Jiang; Jingfei Zhang; Lili Zhang; Tian Wang
Journal:  Eur J Nutr       Date:  2022-01-21       Impact factor: 5.614

5.  Dietary Tributyrin Supplementation Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Suckling Piglets with Intrauterine Growth Retardation.

Authors:  Jintian He; Li Dong; Wen Xu; Kaiwen Bai; Changhui Lu; Yanan Wu; Qiang Huang; Lili Zhang; Tian Wang
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets.

Authors:  Anne Cc Lee; Naoko Kozuki; Simon Cousens; Gretchen A Stevens; Hannah Blencowe; Mariangela F Silveira; Ayesha Sania; Heather E Rosen; Christentze Schmiegelow; Linda S Adair; Abdullah H Baqui; Fernando C Barros; Zulfiqar A Bhutta; Laura E Caulfield; Parul Christian; Siân E Clarke; Wafaie Fawzi; Rogelio Gonzalez; Jean Humphrey; Lieven Huybregts; Simon Kariuki; Patrick Kolsteren; John Lusingu; Dharma Manandhar; Aroonsri Mongkolchati; Luke C Mullany; Richard Ndyomugyenyi; Jyh Kae Nien; Dominique Roberfroid; Naomi Saville; Dianne J Terlouw; James M Tielsch; Cesar G Victora; Sithembiso C Velaphi; Deborah Watson-Jones; Barbara A Willey; Majid Ezzati; Joy E Lawn; Robert E Black; Joanne Katz
Journal:  BMJ       Date:  2017-08-17

7.  Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.

Authors:  Sophie Graner; Tobias Svensson; Anna-Belle Beau; Christine Damase-Michel; Anders Engeland; Kari Furu; Anders Hviid; Siri Eldevik Håberg; Ditte Mølgaard-Nielsen; Björn Pasternak; Helle Kieler
Journal:  BMJ       Date:  2017-02-28

8.  History of periodontal treatment and risk for intrauterine growth restriction (IUGR).

Authors:  Cande V Ananth; Howard F Andrews; Panos N Papapanou; Angela M Ward; Emilie Bruzelius; Mary Lee Conicella; David A Albert
Journal:  BMC Oral Health       Date:  2018-09-29       Impact factor: 2.757

9.  Small for gestational age and risk of childhood mortality: A Swedish population study.

Authors:  Jonas F Ludvigsson; Donghao Lu; Lennart Hammarström; Sven Cnattingius; Fang Fang
Journal:  PLoS Med       Date:  2018-12-18       Impact factor: 11.069

10.  Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.

Authors:  Elizabeth P Schlaudecker; Flor M Munoz; Azucena Bardají; Nansi S Boghossian; Asma Khalil; Hatem Mousa; Mirjana Nesin; Muhammad Imran Nisar; Vitali Pool; Hans M L Spiegel; Milagritos D Tapia; Sonali Kochhar; Steven Black
Journal:  Vaccine       Date:  2017-12-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.